Evaluation of antibodies to the Epstein-Barr virus immediate early gene product ZEBRA by a new enzyme-linked immunosorbent assay

Intervirology

Volumn 41, Issue 6, 1998, Pages 278-284

  Yamauchi, Yasuyuki ^a,b   Tachiband, Yoichi ^b   Maeda, Akihiko ^b,c   Wakiguchi, Hiroshi ^c   Usui, Masahiko ^a   Kurata, Takeshi ^b   Sairenji, Takeshi ^b,d  

^a TOKYO MEDICAL UNIVERSITY HOSPITAL   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c KOCHI MEDICAL SCHOOL   (Japan)

^d TOTTORI UNIVERSITY   (Japan)

Author keywords

Chronic active EBV infection; Enzyme linked immunosorbent assay; Epstein Barr virus; Glutathione S transferase; Immunofluorescence; ZEBRA

Indexed keywords

CELL NUCLEUS ANTIGEN; EARLY ANTIGEN; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; IMMEDIATE EARLY PROTEIN; IMMUNOGLOBULIN G ANTIBODY; MONOCLONAL ANTIBODY; SEPHAROSE; VIRUS ANTIBODY;

ADOLESCENT; ADULT; AFFINITY CHROMATOGRAPHY; ANTIBODY TITER; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; ESCHERICHIA COLI; HUMAN; IMMEDIATE EARLY GENE; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN PURIFICATION; SERODIAGNOSIS; VIRUS INFECTION;

ADOLESCENT; ANIMALS; ANTIBODIES, VIRAL; BLOTTING, WESTERN; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; DNA-BINDING PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EVALUATION STUDIES; FLUORESCENT ANTIBODY TECHNIQUE; GENES, IMMEDIATE-EARLY; GLUTATHIONE TRANSFERASE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT; INFECTIOUS MONONUCLEOSIS; MICE; TRANS-ACTIVATORS; TUMOR VIRUS INFECTIONS; VIRAL PROTEINS;

DNA VIRUSES; ESCHERICHIA COLI; HUMAN HERPESVIRUS 4;

EID: 0032435995     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000024950     Document Type: Article

References (31)

1. Henle W, Henle G, Lennette ET: The Epstein-Barr virus. Sci Am 1979;241:48-59.
2. Rickinson AB, Kieff E: Epstein-Barr virus; in Fields BN, Kinpe DM, Howley PM (eds): Fields Virology, ed 3. Philadelphia, Lippincott-Raven, 1996, pp 2397-2446.
3. Henle W, Henle G, Horwitz C: Epstein-Barr virus specific diagnostic tests in infectious mononucleosis. Hum Pathol 1974;5:551-565.
4. Granlund DJ, Levine PH, Fuccillo DA: Increased sensitivity of new methods for detection of EBV antibodies and implications for infectious mononucleosis. Comp Immunol Microbiol Infect Dis 1979;2:159-165.
5. Hopkins RFd, Witmer TJ, Neubauer RH, Rabin H: Detection of antibodies to Epstein-Barr virus antigens by enzyme-linked immunosorbent assay. J Infect Dis 1982;146:734-740.
6. Kurstak E, de Thé G, van den Hurk J, Charpentier G, Kurstak C, Tijssen P, Morisset R: Detection of Epstein-Barr virus antigens and antibodies by peroxidase-labeled specific immunoglobulins. J Med Virol 1978;2:189-200.
7. Sternas L, Luka J, Kallin B, Rosen A, Henle W, Henle G, Klein G: Enzyme-linked immunosorbent assay for the detection of Epstein-Barr virus-induced antigens and antibodies. J Immunol Methods 1983;63:171-185.
8. Van den Hurk J, Kuratak E: Characterization of Epstein-Barr nuclear antigen (EBNA). 1. A new technique for the detection of EBNA or anti-EBNA-antibodies and its applicability to the study of chromosome-EBNA interactions. J Virol Methods 1980;1:11-26.
9. Dopatka HD, Schuy W: Compact Epstein-Barr virus diagnosis based on a defined antigen mix and specific IgA. Res Virol 1996;147:53-66.
10. Durda PJ, Sullivan M, Kieff E, Pearson GR, Rabin H: An enzyme-linked immunosorbent assay for the measurement of human IgA antibody responses to Epstein-Barr virus membrane antigen. Intervirology 1993;36:11-19.
11. Färber I, Wutzler P, Wohlrabe P, Wolf H, Hinderer W, Sonneborn HH: Serological diagnosis of infectious mononucleosis using three anti-Epstein-Barr virus recombinant ELISAs. J Virol Methods 1993;42:301-308.
12. Geertsen R, Espander-Jansson A, Dobec M, Price P, Wunderli W, Rymo L: Development of a recombinant enzyme-linked immunosorbent assay for detection of antibodies against Epstein-Barr virus nuclear antigens 2A and 2B. J Clin Microbiol 1994;32:112-120.
13. Gorgievski-Hrisoho M, Hinderer W, Nebel Schickel H, Horn J, Vornhagen R, Sonneborn HH, Wolf H, Siegl G: Serodiagnosis of infectious mononucleosis by using recombinant Epstein-Barr virus antigens and enzyme-linked immunosorbent assay technology. J Clin Microbiol 1990;28:2305-2311.
14. Inoue N, Kuranari J, Harada S, Nakajima H, Ohbayashi M, Nakamura Y, Miyasaka N, Ezawa K, Ban F, Yanagi K: Use of enzyme-linked immunosorbent assays with chimeric fusion proteins to titrate antibodies against Epstein-Barr virus nuclear antigen 1. J Clin Microbiol 1992;30:1442-1448.
15. Joab I, Nicolas JC, Schwaab G, de Thé G, Clausse B, Perricaudet M, Zeng Y: Detection of anti-Epstein-Barr-virus transactivator (ZEBRA) antibodies in sera from patients with nasopharyngeal carcinoma. Int J Cancer 1991; 48:647-649.
16. Joab I, Triki H, de Saint Martin J, Perricaudet M, Nicolas JC: Detection of anti-Epstein-Barr virus trans-activator (ZEBRA) antibodies in sera from patients with human immunodeficiency virus. J Infect Dis 1991;163:53-56.
17. Luka J, Chase RC, Pearson GR: A sensitive enzyme-linked immunosorbent assay (ELISA) against the major EBV-associated antigens. I. Correlation between ELISA and immunofluorescence titers using purified antigens. J Immunol Methods 1984;67:145-156.
18. Marechal V, Meyohas MC, Joab I, Gaha S, Giot JF, Sergeant A, Nicolas JC: Enzyme-linked immunosorbent assay for antibodies to ZEBRA, an Epstein-Barr trans-activator. Res Virol 1993;144:397-404.
19. Horwitz CA, Henle W, Henle G, Rudnick H, Latts E: Long-term serological follow-up of patients for Epstein-Barr virus after recovery from infectious mononucleosis. J Infect Dis 1985;151:1150-1153.
20. Sairenji T, Yamanishi K, Tachibana Y, Bertoni G, Kurata T: Antibody responses to Epstein-Barr virus, human herpesvirus 6 and human herpesvirus 7 in patients with chronic fatigue syndrome. Intervirology 1995;38:269-273.
21. Chevallier-Greco A, Manet E, Chavrier P, Mosnier C, Daillie J, Sergeant A: Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter. EMBO J 1986;5:3243-3249.
22. Countryman J, Miller G: Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. Proc Natl Acad Sci USA 1985;82:4085-4089.
23. Taylor N, Countryman J, Rooney C, Katz D, Miller G: Expression of the BZLF1 latency-disrupting gene differs in standard and defective Epstein-Barr viruses. J Virol 1989;63:1721-1728.
24. Smith DB, Johnson KS: Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 1988;67:31-40.
25. Hashimoto Y, Masuko T, Itoh K, Yagita H, Hishinuma T, Degawa M, Kamataki T, Kato R: Monoclonal antibodies against a high spin form of rat cytochrome P-448. Biochem Biophys Res Commun 1985;131:600-606.
26. Rickinson AB: Chronic, symptomatic Epstein-Barr virus infection. Immunol Today 1986;7: 13-14.
27. Wakiguchi H, Fujieda M, Kubota H, Matsumoto K, Wakiguchi A, Kurashige T, Oda M: Elevated IgA antibodies to Epstein-Barr virus in children with chronic active Epstein-Barr virus infection. Acta Med Okayama 1989;43: 193-196.
28. Rabin DU, Palmer-Crocker R, Mierz DV, Yeung KK: An ELISA sandwich capture assay for recombinant fusion proteins containing glutathione-S-transferase. J Immunol Methods 1992;156:101-105.
29. Reedman BM, Klein G: Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int J Cancer 1973;11:499-520.
30. Ginsburg CM, Henle W, Henle G, Horwitz CA: Infectious mononucleosis in children. Evaluation of Epstein-Barr virus-specific serological data. JAMA 1977;237:781-785.
31. Takagi S, Takada K, Sairenji T: Formation of intranuclear replication compartments of Epstein-Barr virus with redistribution of BZLF1 and BMRF1 gene products. Virology 1991; 185:309-315.